Drug Profile
Orazipone
Alternative Names: OR 1384Latest Information Update: 20 Oct 2003
Price :
$50
*
At a glance
- Originator Orion
- Class Small molecules; Sulfhydryl compounds
- Mechanism of Action Immunomodulators; Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Chronic obstructive pulmonary disease; Crohn's disease; Inflammatory bowel diseases
Most Recent Events
- 20 Oct 2003 Discontinued - Phase-I for Asthma in Finland (Inhalation)
- 20 Oct 2003 Discontinued - Phase-I for Chronic obstructive pulmonary disease in Finland (Inhalation)
- 20 Oct 2003 Discontinued - Phase-I for Crohn's disease in Finland (PO)